VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER
申请人:Haick Hossam
公开号:US20130143247A1
公开(公告)日:2013-06-06
The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.
US9315848B2
申请人:——
公开号:US9315848B2
公开(公告)日:2016-04-19
[EN] VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER<br/>[FR] COMPOSÉS ORGANIQUES VOLATILS POUR LA DÉTECTION D'UNE DYSPLASIE CELLULAIRE ET DE MODIFICATIONS GÉNÉTIQUES ASSOCIÉES AU CANCER DU POUMON
申请人:TECHNION RES & DEV FOUNDATION
公开号:WO2012023138A2
公开(公告)日:2012-02-23
The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.
VOLYNSKIJ N. P.; PEREPELITCHENKO L. I., NEFTEXIMIYA, 1981, 21, HO 3, 459-466